biomedical research

Zhen Xu, a researcher at the University of Michigan's biomedical engineering department, has received the Golden Goose Award from the American Association for the Advancement of Science. The award honors federally funded research whose unexpected or seemingly obscure work led to significant societal benefits. Xu's recognition highlights the value of curiosity-driven science, though details of the specific research being honored were not immediately available.

Scientists are increasingly using artificial intelligence to speed up biological design for health research, applying AI tools to engineer proteins, model biological systems and accelerate drug and therapy development. The approach is being highlighted as a way to cut research timelines and expand what laboratories can design, with health reporters examining how the technology is changing biomedical science and what it could mean for future treatments.

Dr. Chris Morrison of Pennington Biomedical Research Center in Baton Rouge has been awarded a grant of up to $2 million from the National Institutes of Health. The funding will support research into how the brain detects dietary protein restriction, work that could shed light on appetite regulation and the health effects of low-protein diets. The award was announced via a science news release.

The Cornell Daily Sun reports on BME 4440, a biomedical engineering course at Cornell University that pushes students to carry their research beyond the classroom and into science policy. The course is framed as an example of how academic work can inform decision-making, connecting technical training with real-world policy applications.

10x Genomics has started global shipments of Atera, a new spatial biology platform the company describes as offering unprecedented capabilities for studying tissue at the molecular level. The launch puts the tool in the hands of researchers worldwide, expanding access to high-resolution spatial analysis. The announcement, issued via PR Newswire, is aimed at laboratories in genomics and biomedical research.

Codebreaker Labs has announced a seed funding round to scale what it describes as first-of-its-kind data infrastructure for genomic AI. The startup aims to build datasets that support artificial intelligence models working on genetic and biomedical research. Details on the investors, the amount raised and the company's specific products have not been widely reported yet.

UChicago Medicine has appointed Josh Denny, a national leader in precision medicine, to a new senior leadership position. Denny is known for his work in genomics and large-scale biomedical research, and his arrival signals the academic health system's intent to expand precision medicine efforts. Details about his exact title and start date were not included in the announcement.

A researcher named Behrmann has been awarded a National Institutes of Health Predoctoral Fellowship, according to an announcement from the University of Missouri School of Medicine. The fellowship supports promising doctoral students in biomedical research. Details about Behrmann's field of study, the award amount, or the research it will fund were not provided in the announcement.

A Wayne State University doctoral student has received support from the National Institutes of Health to fund research into childhood leukemia associated with Down syndrome. Children with Down syndrome face a significantly higher risk of developing leukemia, and the NIH funding will help advance studies aimed at understanding and potentially treating the disease. The award highlights Wayne State's growing biomedical research profile.

Napoleone Ferrara, MD, has been awarded the 2026 Yergin Family International Prize for Biomedical Research. Ferrara is best known for his work on vascular endothelial growth factor (VEGF), which led to major anti-angiogenic therapies for cancer and eye disease. The announcement was made by the Icahn School of Medicine at Mount Sinai, which hosts the prize. Further details about the award ceremony and the prize committee's reasoning were not immediately available.

South Korean biotech Qurient announced that its research has been published in Science Advances, showing that its selective CDK7 inhibitor Q901 works synergistically with TOP1 inhibitor-based antibody-drug conjugates. The finding supports combining Q901 with established cancer treatments and may strengthen the company's position in oncology drug development, drawing attention from investors and the biomedical research community.

Researchers have developed a label-free microfluidic chip paired with artificial intelligence that can identify circulating tumor cells in blood samples. The approach detects cancer cells directly without chemical labels, potentially enabling faster, less invasive cancer diagnostics. The advance is being reported in medical and biotechnology news as a promising step for liquid biopsy and early cancer detection.

Georgia Tech has launched ETHOS, a new initiative aimed at advancing human-centered medical research. Announced via Mirage News, the program is positioned to put patient needs and human factors at the core of biomedical innovation at the institute. Details on funding, partners and specific research areas have not yet been released, but the launch signals Georgia Tech's continued push into healthcare-focused science and technology.